china retractions – Retraction Watch

Despite new retractions, suspect organ transplant papers remain in the literature

Six years after researchers called for the retraction of more than 400 papers about organ transplantation amid suspicion the organs used in the studies came from executed Chinese prisoners, journals are still working to clear the record.

Although more than 40 papers were retracted or otherwise flagged shortly after the 2019 study was published, by our count, only 44 of the 445 papers have been retracted to date. At least 17 of the articles marked with expressions of concern in 2019-2020 remain as such.

The analysis, published in BMJ Open, found more than 400 studies of organ transplants in China that didn’t report whether the sources gave their consent for donation, nor assurances the organs involved did not come from executed prisoners. As reported by The Guardian in 2019, the study exposed “a mass failure of English language medical journals to comply with international ethical standards in place to ensure organ donors provide consent for transplantation.” Thirteen retractions this year directly cite the Rogers paper.

Chinese funding agency penalizes 25 researchers for misconduct

In its second batch of misconduct findings this year, the organization responsible for allocating basic research funding in China has called out 25 researchers for paper mill activity and plagiarism.

The National Natural Science Foundation of China, or NSFC, gives more than 20,000 grants annually in disciplines ranging from agriculture to cancer research. The NSFC publishes the reports periodically “in accordance with relevant regulations,” the first report, released in April, states. The organization awarded 31.9 billion yuan, or about US$4.5 billion, in project funds in 2023.

The NSFC published the results of its investigations on June 13. The reports listed 11 specific papers and 26 grant applications and approvals.

Chinese funding agency sanctions 26 researchers in latest misconduct report

The organization responsible for allocating basic research funding in China has issued misconduct findings against 26 researchers for violations ranging from breach of confidentiality to image manipulation, plagiarism, and buying and selling authorship.

The National Natural Science Foundation of China, or NSFC, released the results of 15 misconduct investigations on April 11. Several of the investigations involved teams of researchers and many included specific published papers, 53 in total. China has been taking steps to crack down on academic fraud, calling last year for a review of all retracted articles in English- and Chinese-language journals.

Penalties for the researchers ranged from bans on applying for funding or serving as a reviewer, to having research funding revoked — which includes having to return funds already dispersed. In most cases, the restrictions on applying for funding were for three to seven years.

Author blames retraction on ‘Chinese censorship’

A former assistant professor of international relations at Yibin University in Sichuan, China, said he was fired from his job and “forced” to retract a paper on COVID-19 because the article did not “paint a good picture of the Chinese government.”

In the 2021 paper, Thomas Ameyaw-Brobbey, now an adjunct lecturer at Accra Business School in Ghana and an adjunct research fellow at the Ghana Armed Forces Command and Staff College, discussed the negative effects of the pandemic on the global public opinion of Chinese leadership and how the outbreak fostered an “unfavorable image” of China.

After the article appeared in the Journal of International Studies, authorities at Yibin University held several meetings with Ameyaw-Brobbey asking him to explain the paper and why he used a dataset of public opinion in the United States that was “likely to be biased towards China,” he said.

University cuts anesthesiology researcher’s funding amid four retractions

An anesthesiologist who had his funding revoked for fabricating data has earned a fourth retraction for publishing the same data in two Springer Nature journals.

Wen-fei Tan, an anesthesiologist at The First Hospital of China Medical University in Shenyang, is the first author of the recently retracted paper “Changes in the first postoperative night bispectral index of patients after thyroidectomy with different types of primary anesthetic management: a randomized controlled trial,” published in the Journal of Clinical Monitoring and Computing (JCMC), a Springer Nature journal, in 2017. It has been cited four times, according to Clarivate’s Web of Science.

The retraction notice states:

Author denies Chinese censorship prompted COVID-19 retraction

The corresponding author of a recently published – and then quickly retracted – letter in The Lancet decrying the failure of the Chinese Ministry of Health to pay doctors and other health care workers says authorities did not pressure him to withdraw the piece.

The letter begins:

As the COVID-19 pandemic comes to an end in China, medical personnel who have worked tirelessly to fight the omicron (B.1.1.529) variant are now facing a new challenge. Despite their heroic efforts, many of them are now struggling to receive the financial compensation they deserve.

The second sentence cites a blog post on Weixin.

Chinese hospital sanctioned at least 35 scientists for research misconduct

Retractions are rolling along for numerous scientists affiliated with the Jining First People’s Hospital in Shandong, China, who were sanctioned in December for research misconduct such as tampering with data and fabricating research.

For example, one article, “Lycium barbarum polysaccharides alleviates oxidative damage induced by H₂O2 through down-regulating microRNA-194 in PC-12 and SH-SY5Y cells,” which appeared in Cellular Physiology and Biochemistry in 2018, was retracted on August 31.

The retraction notice stated:

Frontiers retracts a dozen papers, many more expected

The publisher Frontiers has retracted at least a dozen papers in the last month, after announcing an “extensive internal investigation” into “potentially falsified research.”

Here’s an example of a notice, this one from Frontiers in Endocrinology for “Overexpression of microRNA-216a-3p Accelerates the Inflammatory Response in Cardiomyocytes in Type 2 Diabetes Mellitus by Targeting IFN-α2,” which was originally published in November 2020:

Cancer journal with hefty retraction record retracts another 15

A cancer journal with a history of batch retractions has pulled 15 articles dating back to 2014 after concluding that they contained manipulated or misused images.

As we reported in 2017, Tumor Biology was forced to retract 107 papers that had been corrupted by fake peer review – a record at the time. That move had followed a similar, if smaller, sweep in 2016 by the journal, which was owned by Springer but purchased by SAGE in December 2016 after the more massive cleanse.

Researcher loses medical degree for using paper mill to write his dissertation

A university in China has revoked the medical degree of a researcher found guilty of having produced his dissertation with the help of a prodigious paper mill.

As Elisabeth Bik noted last year in a post on PubPeer, the thesis by Bin Chen, a lung specialist at Soochow University, was one of 121 articles produced by the paper mill that:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: